KonTEM

Exit

Sample analysis in structural biology often suffers from weak contrast in the transmission electron microscope (TEM). The KonTEM PhazR solves this contrast problem and thus enables scientists to extract more information about structure and function of cells on molecular level.

Exit since May 2014. Purchaser: FEI Company (NASDAQ: FEIC)

Management

Jörg Wamser

Pressemeldungen

Profitable exit: KonTEM trade sale to FEI Company (NASDAQ: FEIC)

KonTEM GmbH, an HTGF-financed spin-off of the Max Planck Society and the research centre caesar, was taken over by FEI Company on a share deal basis. Thus the phase contrast technology developed by KonTEM is absorbed in the portfolio of a globally operating market leader in the field of high-performance microscopy…
Read

High-Tech Gründerfonds invests in KonTEM GmbH

Joint press release of High-Tech Gründerfonds, Max-Planck-Innovation GmbH, Center of advanced european studies and research (caesar) and KonTEM GmbH. KonTEM GmbH, a spin-off company of the Max-Planck-Gesellschaft (MPG) and the Center of advanced european studies and research (caesar), has developed an innovative…
Read

Info & Contact

Phone:
+49 228 180 33 200
Web:
www.kontem.de

Address

Ludwig-Erhard-Allee 2
53175 Bonn

In portfolio

04. Apr 2012 – 02. May 2014
Exit